Nuveen LLC Makes New Investment in Hims & Hers Health, Inc. $HIMS

Key Points

• Nuveen LLC has invested approximately $58.40 million in Hims & Hers Health, acquiring 1,976,425 shares, representing 0.88% ownership of the company.
• Hims & Hers Health reported earnings with a net margin of 9.63% and revenue growth of 72.6% year-over-year, although it missed EPS estimates by $0.01.
• Analysts maintain a consensus rating of "Hold" on Hims & Hers Health shares, with a consensus target price of $39.83, as several analysts have reiterated their positions recently.

Nuveen LLC bought a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,976,425 shares of the company's stock, valued at approximately $58,403,000. Nuveen LLC owned about 0.88% of Hims & Hers Health as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Connor Clark & Lunn Investment Management Ltd. boosted its position in Hims & Hers Health by 3.7% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,216,499 shares of the company's stock worth $35,948,000 after purchasing an additional 43,525 shares in the last quarter. National Bank of Canada FI boosted its position in Hims & Hers Health by 48.4% during the first quarter. National Bank of Canada FI now owns 4,436 shares of the company's stock worth $131,000 after purchasing an additional 1,446 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Hims & Hers Health by 10.6% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 56,307 shares of the company's stock worth $1,664,000 after purchasing an additional 5,400 shares in the last quarter. CenterBook Partners LP purchased a new position in Hims & Hers Health during the first quarter worth approximately $3,896,000. Finally, Citizens Financial Group Inc. RI purchased a new position in Hims & Hers Health during the first quarter worth approximately $310,000. Hedge funds and other institutional investors own 63.52% of the company's stock.

Hims & Hers Health Trading Down 0.9%

Hims & Hers Health stock traded down $0.41 during trading on Monday, reaching $45.61. 11,151,028 shares of the company were exchanged, compared to its average volume of 33,865,355. Hims & Hers Health, Inc. has a 52-week low of $13.47 and a 52-week high of $72.98. The company has a market capitalization of $10.31 billion, a P/E ratio of 57.06, a PEG ratio of 2.91 and a beta of 2.08. The company has a debt-to-equity ratio of 1.72, a current ratio of 4.98 and a quick ratio of 4.46. The stock's 50 day simple moving average is $52.96 and its two-hundred day simple moving average is $45.72.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%. The company had revenue of $544.83 million for the quarter, compared to analysts' expectations of $550.06 million. During the same quarter in the previous year, the business posted $0.06 EPS. The business's quarterly revenue was up 72.6% compared to the same quarter last year. On average, equities research analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Analysts Set New Price Targets

HIMS has been the topic of a number of recent analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of Hims & Hers Health in a research report on Tuesday, August 5th. Truist Financial lowered their price target on Hims & Hers Health from $48.00 to $37.00 and set a "hold" rating on the stock in a research report on Monday. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Hims & Hers Health in a research report on Wednesday, May 7th. UBS Group set a $30.00 price target on Hims & Hers Health in a research report on Monday, June 23rd. Finally, Piper Sandler restated a "neutral" rating and issued a $39.00 target price (up previously from $35.00) on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $38.92.

Insider Buying and Selling

In related news, insider Michael Chi sold 17,102 shares of Hims & Hers Health stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total transaction of $1,021,844.50. Following the transaction, the insider owned 278,654 shares in the company, valued at approximately $16,649,576.50. This trade represents a 5.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Andrew Dudum sold 660,000 shares of Hims & Hers Health stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $50.58, for a total value of $33,382,800.00. Following the transaction, the chief executive officer owned 2,214,769 shares in the company, valued at approximately $112,023,016.02. The trade was a 22.96% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,273,034 shares of company stock worth $66,425,573. 17.71% of the stock is owned by corporate insiders.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.